References
- Faine S, Adler B, Bolin C, et al. Leptospira and Leptospirosis. 2nd ed. Melbourne (Australia): MediSci; 1999.
- Ko AI, Goarant C, Picardeau M. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol. 2009;7:736–747.
- Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14:296–326.
- Trevejo RT, Rigau-Pérez JG, Ashford DA, et al. Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis. 1998;178:1457–1463.
- Laurichesse H, Gourdon F, Smits HL, et al. Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteers. Clin Microbiol Infect. 2007;13:395–403.
- Martínez R, Pérez A, MeC Q, et al. Efficacy and safety of a vaccine against human leptospirosis in Cuba. Rev Panam Salud Publica. 2004;15:249–255.
- Yan Y, Chen Y, Liou W, et al. An evaluation of the serological and epidemiological effects of the outer envelope vaccine to leptospira. J Chin Med Assoc. 2003;66:224–230.
- Yanagihara Y, Villanueva SY, Yoshida S, et al. Current status of leptospirosis in Japan and Philippines. Comp Immunol Microbiol Infect Dis. 2007;30:399–413.
- Teixeira AF, de Morais ZM, Kirchgatter K, et al. Features of two new proteins with OmpA-like domains identified in the genome sequences of Leptospira interrogans. PLoS One. 2015;10:e0122762.
- Vieira ML, Fernandes LG, Domingos RF, et al. Leptospiral extracellular matrix adhesins as mediators of pathogen-host interactions. FEMS Microbiol Lett. 2014;352:129–139.
- Fernandes LG, de Morais ZM, Vasconcellos SA, et al. Leptospira interrogans reduces fibrin clot formation by modulating human thrombin activity via exosite I. Pathog Dis. 2015;73:ftv001.
- Domingos RF, Vieira ML, Romero EC, et al. Features of two proteins of Leptospira interrogans with potential role in host-pathogen interactions. BMC Microbiol. 2012;12:50.
- Oliveira R, Domingos RF, Siqueira GH, et al. Adhesins of Leptospira interrogans mediate the interaction to fibrinogen and inhibit fibrin clot formation in vitro. PLoS Negl Trop Dis. 2013;7:e2396.
- Pereira PRM, Fernandes LGV, de Souza GO, et al. Multifunctional and redundant roles of Leptospira interrogans proteins in bacterial-adhesion and fibrin clotting inhibition. Int J Med Microbiol. 2017;307:297–310.
- Vieira ML, Vasconcellos SA, Gonçales AP, et al. Plasminogen acquisition and activation at the surface of leptospira species lead to fibronectin degradation. Infect Immun. 2009;77:4092–4101.
- Siqueira GH, de Souza GO, Heinemann MB, et al. The role of Lsa23 to mediate the interaction of Leptospira interrogans with the terminal complement components pathway. Microb Pathog. 2017;112:182–189.
- Siqueira GH, Atzingen MV, de Souza GO, et al. Leptospira interrogans Lsa23 protein recruits plasminogen, factor H and C4BP from normal human serum and mediates C3b and C4b degradation. Microbiology. 2016;162:295–308.
- Oliveira TL, Bacelo KL, Schuch RA, et al. Immune response in hamsters immunised with a recombinant fragment of LigA from Leptospira interrogans, associated with carrier molecules. Mem Inst Oswaldo Cruz. 2016;111:712–716.
- Silva LP, Fernandes LG, Vieira ML, et al. Evaluation of two novel leptospiral proteins for their interaction with human host components. Pathog Dis. 2016;74:ftw040.
- Malmström J, Beck M, Schmidt A, et al. Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans. Nature. 2009;460:762–765.
- Ellinghausen HC, McCullough WG. Nutrition of leptospira pomona and growth of 13 other serotypes: a serum-free medium employing oleic albumin complex. Am J Vet Res. 1965;26:39–44.
- Nascimento AL, Ko AI, Martins EA, et al. Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J Bacteriol. 2004;186:2164–2172.
- Nascimento AL, Verjovski-Almeida S, Van Sluys MA, et al. Genome features of Leptospira interrogans serovar Copenhageni. Braz J Med Biol Res. 2004;37:459–477.
- Yu CS, Chen YC, Lu CH, et al. Prediction of protein subcellular localization. Proteins. 2006;64:643–651.
- Nakai K, Kanehisa M. Expert system for predicting protein localization sites in gram-negative bacteria. Proteins. 1991;11:95–110.
- Juncker AS, Willenbrock H, Von Heijne G, et al. Prediction of lipoprotein signal peptides in Gram-negative bacteria. Protein Sci. 2003;12:1652–1662.
- Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol. 1990;215:403–410.
- Ramos CR, Abreu PA, Nascimento AL, et al. A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz J Med Biol Res. 2004;37:1103–1109.
- Santos JV, Pereira PRM, Fernandes LGV, et al. Binding of human plasminogen by the lipoprotein LipL46 of Leptospira interrogans. Mol Cell Probes. 2018;37:12–21.
- Micsonai A, Wien F, Kernya L, et al. Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy. Proc Natl Acad Sci U S A. 2015;112:E3095–3E103.
- Micsonai A, Wien F, É B, et al. BeStSel: a web server for accurate protein secondary structure prediction and fold recognition from the circular dichroism spectra. Nucleic Acids Res. 2018;46:W315–W322.
- Jones DT. Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol. 1999;292:195–202.
- Buchan DWA, Jones DT. The PSIPRED Protein Analysis Workbench: 20 years on. Nucleic Acids Res. 2019;gkz297:1–6.
- Gruber A, Zingales B. Alternative method to remove antibacterial antibodies from antisera used for screening of expression libraries. Biotechniques. 1995;19:28, 30.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
- Fernandes LGV, Vieira ML, Kirchgatter K, et al. OmpL1 is an extracellular matrix- and plasminogen-interacting protein of Leptospira spp. Infect Immun. 2012;80:3679–3692.
- Matsunaga J, Werneid K, Zuerner RL, et al. LipL46 is a novel surface-exposed lipoprotein expressed during leptospiral dissemination in the mammalian host. Microbiology. 2006;152:3777–3786.
- Haake DA, Matsunaga J. Characterization of the leptospiral outer membrane and description of three novel leptospiral membrane proteins. Infect Immun. 2002;70:4936–4945.
- Ballard SA, Go M, Segers RP, et al. Molecular analysis of the dnaK locus of Leptospira interrogans serovar Copenhageni. Gene. 1998;216:21–29.
- Oliveira TR, Longhi MT, de Morais ZM, et al. Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays. Clin Vaccine Immunol. 2008;15:1715–1722.
- Lähteenmäki K, Kuusela P, Korhonen TK. Bacterial plasminogen activators and receptors. FEMS Microbiol Rev. 2001;25:531–552.
- Vieira ML, Atzingen MV, Oliveira TR, et al. In vitro identification of novel plasminogen-binding receptors of the pathogen Leptospira interrogans. PLoS One. 2010;5:e11259.
- Picardeau M, Bulach DM, Bouchier C, et al. Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS One. 2008;3:e1607.
- Oliveira TR, Longhi MT, Gonçales AP, et al. LipL53, a temperature regulated protein from Leptospira interrogans that binds to extracellular matrix molecules. Microbes Infect. 2010;12:207–217.
- Pinne M, Haake DA. A comprehensive approach to identification of surface-exposed, outer membrane-spanning proteins of Leptospira interrogans. PLoS One. 2009;4:e6071.
- Atzingen MV, Barbosa AS, De Brito T, et al. Lsa21, a novel leptospiral protein binding adhesive matrix molecules and present during human infection. BMC Microbiol. 2008;8:70.
- Yavlovich A, Higazi AA, Rottem S. Plasminogen binding and activation by Mycoplasma fermentans. Infect Immun. 2001;69:1977–1982.
- Hammerschmidt C, Klevenhaus Y, Koenigs A, et al. BGA66 and BGA71 facilitate complement resistance of Borrelia bavariensis by inhibiting assembly of the membrane attack complex. Mol Microbiol. 2016;99:407–424.
- Hallström T, Siegel C, Mörgelin M, et al. CspA from Borrelia burgdorferi inhibits the terminal complement pathway. MBio. 2013;4.
- Stone BL, Brissette CA. Host immune evasion by Lyme and relapsing fever Borreliae: findings to lead future studies for Borrelia miyamotoi. Front Immunol. 2017;8:12.
- Meri T, Murgia R, Stefanel P, et al. Regulation of complement activation at the C3-level by serum resistant leptospires. Microb Pathog. 2005;39:139–147.
- Ito T, Yanagawa R. Leptospiral attachment to four structural components of extracellular matrix. Nihon Juigaku Zasshi. 1987;49:875–882.
- Evangelista KV, Hahn B, Wunder EA, et al. Identification of cell-binding adhesins of Leptospira interrogans. PLoS Negl Trop Dis. 2014;8:e3215.
- Fernandes LG, Siqueira GH, Teixeira AR, et al. Leptospira spp.: Novel insights into host-pathogen interactions. Vet Immunol Immunopathol. 2016;176:50–57.
- Barbosa AS, Abreu PA, Neves FO, et al. A newly identified leptospiral adhesin mediates attachment to laminin. Infect Immun. 2006;74:6356–6364.
- Eshghi A, Gaultney RA, England P, et al. An extracellular Leptospira interrogans leucine-rich repeat protein binds human E- and VE-cadherins. Cell Microbiol. 2019;21:e12949.
- Evangelista K, Franco R, Schwab A, et al. Leptospira interrogans binds to cadherins. PLoS Negl Trop Dis. 2014;8:e2672.
- Domingos RF, Fernandes LG, Romero EC, et al. Novel Leptospira interrogans protein Lsa32 is expressed during infection and binds laminin and plasminogen. Microbiology. 2015;161:851–864.
- Vieira ML, Atzingen MV, Oliveira R, et al. Plasminogen binding proteins and plasmin generation on the surface of Leptospira spp.: the contribution to the bacteria-host interactions. J Biomed Biotechnol. 2012;2012:758513.
- Mendes RS, Von Atzingen M, de Morais ZM, et al. The novel leptospiral surface adhesin Lsa20 binds laminin and human plasminogen and is probably expressed during infection. Infect Immun. 2011;79:4657–4667.
- Souza NM, Vieira ML, Alves IJ, et al. Lsa30, a novel adhesin of Leptospira interrogans binds human plasminogen and the complement regulator C4bp. Microb Pathog. 2012;53:125–134.
- Cinco M, Banfi E. Activation of complement by leptospires and its bactericidal activity. Zentralbl Bakteriol Mikrobiol Hyg A. 1983;254:261–265.
- Vieira ML, de Morais ZM, Vasconcellos SA, et al. In vitro evidence for immune evasion activity by human plasmin associated to pathogenic Leptospira interrogans. Microb Pathog. 2011;51:360–365.
- Preissner KT. Structure and biological role of vitronectin. Annu Rev Cell Biol. 1991;7:275–310.
- Milis L, Morris CA, Sheehan MC, et al. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9. Clin Exp Immunol. 1993;92:114–119.
- Atzingen MV, Gonçales AP, de Morais ZM, et al. Characterization of leptospiral proteins that afford partial protection in hamsters against lethal challenge with Leptospira interrogans. J Med Microbiol. 2010;59:1005–1015.
- Evangelista KV, Lourdault K, Matsunaga J, et al. Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis. PLoS One. 2017;12:e0180004.
- Fernandes LG, Teixeira AF, Filho AF, et al. Immune response and protective profile elicited by a multi-epitope chimeric protein derived from Leptospira interrogans. Int J Infect Dis. 2017;57:61–69.
- Cullen PA, Haake DA, Adler B. Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol Rev. 2004;28:291–318.